📑Padm8: Ao2021 pharmauvergne fournitures dispositifs medicaux segment trois
Procurement process summary
This process is to purchase Padm8: Ao2021 pharmauvergne fournitures dispositifs medicaux segment trois.
This contract was awarded by 🇫🇷 CHU de Clermont-Ferrand for an amount of EUR 90,000,000 to 1 supplier. It was published on 2020-05-19 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇫🇷 CHU de Clermont-Ferrand Buying unitnot reported Publication date2020-05-19 Contest statusnot reported DescriptionPADM8: AO2021 -- Pharm Auvergne fournitures dispositifs medicaux segment 3.Awards
This award was granted to Alcon by CHU de Clermont-Ferrand for an amount of EUR 90,000,000. The procurement process was conducted through open for the category of goods. This is award number 63.
This contract has multiple awards. This is award number 63. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇫🇷 Alcon | EUR 90,000,000 | 63 |
Market context and opportunities
The execution of this contract allows the entity CHU de Clermont-Ferrand to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberFR_ocds-70d2nz-f7b3f255-589f-4138-a610-44aa8d983093-award-63Publication date2020-05-19Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
